HOME >> MEDICINE >> NEWS
Exploring better ways to determine when to change the course of treatment

Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made. The results of a large, multicenter, international study laying the groundwork for such decisions were presented today at the Annual Meeting of the American Society of Clinical Oncology. The study showed the number of circulating tumor cells, or CTC, is a significant predictor of survival and cancer progression.

Few studies have examined the relationship of CTC and a patient's prognosis in cancer. This is an important area of research in metastatic colorectal cancer because there are little data to help physicians chose which treatment is best for which patients or to determine when a change in treatment is warranted.

"If we had a way to know early on that a tumor isn't responding to a particular drug, we could switch to a different treatment before growth of the cancer is seen on a CAT scan," said Neal J. Meropol, director of the gastrointestinal cancer program at Fox Chase Cancer Center and lead investigator of the study. "If we could determine that the tumor was destined to grow after a few weeks of treatment, we'd be able alter course even before the first scan."

For this study, Meropol and his colleagues examined the association between the circulating tumor cell number and progression-free and overall survival for 430 adult patients with metastatic colorectal cancer.

The number of CTC was measured at baseline, one month, and several other points after the start of treatment. CTC were isolated and counted by an immunomagnetic cell separation technique, an FDA-approved technology developed by Immunicon Corporation (Nasdaq-Global Market: IMMC}. CT scans were obtained in usual practiceat baseline and every 6-12 weeks after starting treatment.

Having 3 or more CTC (per 7.5 mL of blood) was defined as "unfavo
'"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
215-728-9751
Fox Chase Cancer Center
3-Jun-2007


Page: 1 2

Related medicine news :

1. Exploring the molecular origin of blood clot flexibility
2. Exploring the potential of cholesterol-lowering drugs for patients with systemic sclerosis
3. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
6. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
7. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
8. Holograms make for better vision tests
9. Parents of chronically ill kids are helped by better access to federal and employer leave
10. Diabetes professionals join forces to identify gaps in diabetes care and better self care
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... LOS ANGELES (PRWEB) , ... February 13, 2019 , ... ... first at-home sexually transmitted disease (STD) testing service, is sharing 7 tips to ensure ... relationship and especially if you’re going to engage in safe sex. Having clear, open, ...
(Date:2/13/2019)... ... February 13, 2019 , ... Castle announced today that ... participation from existing investors Y Combinator , First Round and ... at Duo Security, René Bonvanie, CMO at Palo Alto Networks, and Olivier Pomel, CEO ...
(Date:2/13/2019)... OMAHA, Neb. (PRWEB) , ... February 13, 2019 , ... ... – Employer of Choice Award from Home Care Pulse. The Employer of Choice Award ... gathered by Home Care Pulse, an independent satisfaction research firm for home care. A ...
(Date:2/13/2019)... ... ... Dakota Dental Health Center in Minot, ND, is pleased to announce the launch ... of Dakota Dental, the new website is a convenient tool that allows patients the ... improve their oral health. , The new website is equally responsive on smartphones, ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... workshop from FDAnews and Ombu Enterprises**, Feb. 19-20, 2019, Atlanta, GA , ... Prepare for the Winds of Change on Jan. 22 , Risk management is ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... ... in Bogotá, Colombia. The new program opens possibilities for childless couples who are ... , Until now, childless couples have been limited to North America or Eastern ...
(Date:2/13/2019)... ... , ... WellRyde, a nuVizz Inc transportation solution, announces the successful integration with ... of Trip Market in early August 2018, WellRyde has seen an increase in trip ... Market has contributed significantly to the annual trip volume of 16+ Million trips. NEMT ...
(Date:2/13/2019)... ... February 13, 2019 , ... The Pathfinder Network ... February 13-15, 2019, at the Salem Convention Center (SCC) in Salem, Oregon. The ... panels and workshops led by local and national experts about successful and innovative ...
Breaking Medicine Technology:
Cached News: